Development of a CHO cell-produced PEDV GIIc S protein subunit vaccine candidate and evaluation of its immunogenicity

Porcine epidemic diarrhea virus (PEDV) causes severe diarrhea and high mortality in neonatal piglets, resulting in substantial economic losses for the global swine industry. In recent years, the PEDV GIIc genotype has emerged as the predominant circulating strain in China. Its antigenic characteristics differ from those of traditional vaccine strains, limiting the protective efficacy of existing vaccines. The spike (S) protein, a key structural protein responsible for inducing neutralizing antibodies and cellular immunity, serves as a prime candidate antigen for the development of PEDV subunit vaccines. In this study, a subunit vaccine was developed based on the S protein of the circulating PEDV GIIc strain; a CHO cell line stably expressing high levels of the S protein was established, enabling the production and purification of the recombinant S protein. Immunogenicity evaluations demonstrated that the S protein subunit vaccine elicited robust S protein-specific antibody responses and promoted antigen-specific cellular immune activation in mice. Furthermore, analysis of IgG subclasses showed that both IgG1 and IgG2a levels were elevated following immunization, and the IgG1/IgG2a ratio was greater than 1, suggesting a relative predominance of the IgG1 response. Compared to commercial inactivated vaccines, the two groups exhibited different immune response characteristics in terms of antigen-specific T-cell immunity, spleen cell proliferation, and the secretion of cytokines such as IFN-γ and IL-4. In conclusion, the S protein subunit vaccine is capable of eliciting both humoral and cellular immune responses, providing a candidate strategy and technical foundation for the development of novel vaccines targeting the currently prevalent PEDV GIIc strain. However, this study primarily evaluated the vaccine’s immunogenicity; its actual protective efficacy against PEDV infection still needs to be verified through further neutralization activity and challenge protection tests.

Authors

Institutions

Publication Details

Journal
Frontiers in Cellular and Infection Microbiology
Published
2026-11-18
DOI
https://doi.org/10.3389/fcimb.2026.1977001
Primary Topic
Animal Virus Infections Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development of a CHO cell-produced PEDV GIIc S protein subunit vaccine candidate and evaluation of its immunogenicity

Weifeng Gao, Nan Song, Yong Li, Qiang Liu et al.
6 links
Frontiers in Cellular and Infection Microbiology
Animal Virus Infections Studies
article

Development of a CHO cell-produced PEDV GIIc S protein subunit vaccine candidate and evaluation of its immunogenicity

Weifeng Gao, Nan Song, Yong Li, Qiang Liu, Zhuolin Liu, Fangyuan Tian, Lu Chen
article en

Abstract

Porcine epidemic diarrhea virus (PEDV) causes severe diarrhea and high mortality in neonatal piglets, resulting in substantial economic losses for the global swine industry. In recent years, the PEDV GIIc genotype has emerged as the predominant circulating strain in China. Its antigenic characteristics differ from those of traditional vaccine strains, limiting the protective efficacy of existing vaccines. The spike (S) protein, a key structural protein responsible for inducing neutralizing antibodies and cellular immunity, serves as a prime candidate antigen for the development of PEDV subunit vaccines. In this study, a subunit vaccine was developed based on the S protein of the circulating PEDV GIIc strain; a CHO cell line stably expressing high levels of the S protein was established, enabling the production and purification of the recombinant S protein. Immunogenicity evaluations demonstrated that the S protein subunit vaccine elicited robust S protein-specific antibody responses and promoted antigen-specific cellular immune activation in mice. Furthermore, analysis of IgG subclasses showed that both IgG1 and IgG2a levels were elevated following immunization, and the IgG1/IgG2a ratio was greater than 1, suggesting a relative predominance of the IgG1 response. Compared to commercial inactivated vaccines, the two groups exhibited different immune response characteristics in terms of antigen-specific T-cell immunity, spleen cell proliferation, and the secretion of cytokines such as IFN-γ and IL-4. In conclusion, the S protein subunit vaccine is capable of eliciting both humoral and cellular immune responses, providing a candidate strategy and technical foundation for the development of novel vaccines targeting the currently prevalent PEDV GIIc strain. However, this study primarily evaluated the vaccine’s immunogenicity; its actual protective efficacy against PEDV infection still needs to be verified through further neutralization activity and challenge protection tests.

Frontiers in Cellular and Infection MicrobiologyVol. 16
Ningxia University (CN)
Good health and well-being
Animal Virus Infections Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon